Voriconazole Sandoz

Voriconazole Sandoz Indications/Uses





Zuellig Pharma
Full Prescribing Info
Voriconazole is a broad spectrum, triazole antifungal agent and is indicated in adults and children aged 2 years and above as follows: Treatment of invasive aspergillosis.
Treatment of candidemia in non-neutropenic patients.
Treatment of fluconazole-resistant serious invasive Candida infections (including C. krusei).
Treatment of esophageal candidiasis.
Treatment of serious fungal infections caused by Scedosporium spp. and Fusarium spp.
Treatment of other serious fungal infections in patients intolerant of, or refractory to, other therapy.
Prevention of breakthrough of fungal infections in febrile high-risk patients (allogenic bone marrow transplants, relapsed leukemia patients).
Prophylaxis in patients who are at high risk of developing invasive fungal infections, such as haematopoietic stem cell transplant (HSCT) recipients.
Voriconazole should be administered primarily to patients with progressive, possibly life-threatening infections.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in